Article Sidebar

pdf
Date Published: 07/09/2024
Abstract Views: 40
Views pdf: 21
DOI: https://doi.org/10.51298/vmj.v541i3.10861
Issue
Vol. 541 No. 3 (2024)
Section
Các bài báo
How to Cite
Bùi, M. T., & Nguyễn, Q. T. (2024). CLINICAL AND PARA-CLINICAL CHARACTERISTICS OF PATIENTS WITH POLYCYSTIC OVARIAN SYNDROME TREATED AT THAI BINH MEDICAL UNIVERSITY HOSPITAL. Vietnam Medical Journal, 541(3). https://doi.org/10.51298/vmj.v541i3.10861

CLINICAL AND PARA-CLINICAL CHARACTERISTICS OF PATIENTS WITH POLYCYSTIC OVARIAN SYNDROME TREATED AT THAI BINH MEDICAL UNIVERSITY HOSPITAL

Minh Tiến Bùi, Quý Thạo Nguyễn

Main Article Content

Abstract

Introduction: Polycystic ovary syndrome (PCOS) is the most commonly diagnosed endocrine disorder in women and is a leading cause of infertility due to anovulation. Early diagnosis of PCOS is crucial to reduce the risk of long-term complications for women, hence we conducted a study with the purpose: “To describe some clinical and subclinical characteristics of patients with polycystic ovary syndrome at Thai Binh University of Medicine  Hospital in 2021”. Study subjects and methods: A descriptive cross-sectional analysis of 34 PCOS patients diagnosed according to the ESRHE/ASRM Rotterdam 2003 criteria was conducted from January 1, 2021, to June 30, 2021. Results: The age group 25-29 had the highest proportion with 58.8%, the number of primary infertility was nearly twice that of secondary infertility (23 vs. 11), and the order of phenotype ratios in PCOS was D-A-C-B. The average LH concentration was 10.27 ± 4.29. Conclusion: The phenotypic expression of PCOS in the study was entirely consistent with the ESRHE/ASRM Rotterdam 2003 criteria.

Article Details

Keywords

Clinical, subclinical, polycystic ovary syndrome, Thai Binh.

References

1. N. F. Goodman, R. H. Cobin, W. Futterweit, et al (2015). American association of clinical endocrinologists, american college of endocrinology, and androgen excess and pcos society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome--part 1. Endocr Pract. 21(11), 1291-300.
2. J. A. Lentscher, B. Slocum và S. Torrealday (2021). Polycystic Ovarian Syndrome and Fertility. Clin Obstet Gynecol. 64(1), 65-75.
3. Giovanna Muscogiuri, Barbara Altieri, Cristina de Angelis, et al (2017). Shedding new light on female fertility: The role of vitamin D. 18, 273-283.
4. W. M. Wolf, R. A. Wattick, O. N. Kinkade, et al (2018). Geographical Prevalence of Polycystic Ovary Syndrome as Determined by Region and Race/ Ethnicity. Int J Environ Res Public Health. 15(11).
5. The Rotterdam ESHRE/ASRM‐sponsored PCOS consensus workshop group (2004). Revised 2003 consensus on diagnostic criteria and long‐term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction. 19(1), 41-47.
6. Stephen Franks, Mark I McCarthy và Kate %J. International journal of andrology Hardy (2006). Development of polycystic ovary syndrome: involvement of genetic and environmental factors. 29(1), 278-285.
7. Gurkan Bozdag, Sezcan Mumusoglu, Dila Zengin, et al (2016). The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Human Reproduction. 31(12), 2841-2855.
8. Revised 2003. consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (2004). Fertil Steril. 81(1), 19-25.
9. Đào Mạnh Tín (2018). So sánh hiệu quả kích thích buồng trứng giữa Letrozole và Clomiphene citrate trên bệnh nhân có chỉ định bơm tinh trùng vào buồng tử cung, Luận văn thạc sĩ y học, Trường đại học y Hà Nội, Trường đại học y Hà Nội.
10. N. T. Cao, M. T. Le, V. Q. H. Nguyen, et al (2019). Defining polycystic ovary syndrome phenotype in Vietnamese women. J Obstet Gynaecol Res. 45(11), 2209-2219.